Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe

BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is increasingly recognized as a persistent disorder requiring long-term management. OBJECTIVES: Our objective was to evaluate the 2-year safety and efficacy of lisdexamfetamine dimesylate (LDX) in children and adolescents with ADHD. METHODS...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :CNS Drugs
Главные авторы: Coghill, David R., Banaschewski, Tobias, Nagy, Peter, Otero, Isabel Hernández, Soutullo, César, Yan, Brian, Caballero, Beatriz, Zuddas, Alessandro
Формат: Artigo
Язык:Inglês
Опубликовано: Springer International Publishing 2017
Предметы:
Original Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5511319/
https://ncbi.nlm.nih.gov/pubmed/28667569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-017-0443-y
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы